Vertex taps California startup for $700M gene-editing deal
October 27, 2021 at 16:50 PM EDT
Vertex has developed cystic fibrosis therapies and is working with other partners on CRISPR-Cas9 systems as well as messenger RNA, or MRNA, therapies with Moderna Inc.
